USE OF GLP-1 RECEPTOR AGONISTS AND/OR SGLT-2 INHIBITORS AMONG PATIENTS WITH PERIPHERAL ARTERY DISEASE BEFORE AND AFTER REVASCULARIZATION IN A SINGLE-CENTER COHORT

Therapeutic Area: Peripheral Artery Disease Background: Diabetes mellitus (DM) is a major risk factor for peripheral artery disease (PAD). Patients with both PAD and DM have an increased risk of major adverse atherosclerotic events. GLP-1 RA and SGLT-2i are recommended to improve major adverse cardi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Autor Principal: Franck H. Azobou Tonleu, MD (Author)
Formato: Libro
Publicado: Elsevier, 2024-09-01T00:00:00Z.
Subjects:
Acceso en liña:Connect to this object online.
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Dispoñible